There is disclosed the use of a compound of formula (I), (I) wherein X, Y, W and Q are as defined in the specification, and pharmaceutically acceptable salts thereof, in the manufacture of a medicament, for the treatment or prophylaxis of diseases or conditions in which inhibition of the enzyme myeloperoxidase (MPO) is beneficial. Certain novel compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed, together with processes for their preparation. The compounds of formulae (I) are MPO inhibitors and are thereby particularly useful in the treatment or prophylaxis of neuroinflammatory disorders.
本发明揭示了一种使用式(I)化合物及其药学上可接受的盐在制备药物方面的应用,用于治疗或预防抑制髓
过氧化物酶(MPO)酶有益的疾病或病症。本发明还揭示了某些新型式(I)化合物及其药学上可接受的盐,以及它们的制备过程。式(I)化合物是MPO
抑制剂,因此在治疗或预防神经炎性疾病方面特别有用。